Blueprint Medicines Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	84.59	128.11	96.07	135.19	88.55	Upgrade
Revenue Growth (YoY)	-33.97%	33.35%	-28.94%	52.68%	-39.40%	Upgrade
Cost of Revenue	44.94	60.62	44.19	62.26	48.04	Upgrade
Gross Profit	39.65	67.49	51.88	72.93	40.51	Upgrade
Selling, General & Admin	53.62	73.2	69.95	88.59	64.71	Upgrade
Other Operating Expenses	-5.48	-2.88	-2.4	-2.24	-2.99	Upgrade
Operating Expenses	48.04	69.48	68.84	85.9	65.14	Upgrade
Operating Income	-8.39	-1.99	-16.96	-12.97	-24.63	Upgrade
Interest Expense	-1.47	-1.42	-0.66	-0.44	-0.64	Upgrade
Interest & Investment Income	0.02	0.04	0.06	0.17	0.14	Upgrade
Currency Exchange Gain (Loss)	-	-	-	1	2.36	Upgrade
Other Non Operating Income (Expenses)	-	-2.32	0.02	1.03	4.85	Upgrade
EBT Excluding Unusual Items	-9.85	-5.69	-17.53	-11.21	-17.92	Upgrade
Gain (Loss) on Sale of Investments	0.03	0.13	0.12	0.17	0.16	Upgrade
Asset Writedown	-0.85	-	-	-	-	Upgrade
Other Unusual Items	0.12	-	0.06	-	0.45	Upgrade
Pretax Income	-10.55	-5.55	-17.34	-11.04	-17.32	Upgrade
Income Tax Expense	0.14	1.7	-0.21	-0.93	-0.41	Upgrade
Earnings From Continuing Operations	-10.69	-7.26	-17.13	-10.11	-16.91	Upgrade
Minority Interest in Earnings	0.68	-0.99	0.84	1.51	0.9	Upgrade
Net Income	-10.01	-8.25	-16.3	-8.6	-16.01	Upgrade
Net Income to Common	-10.01	-8.25	-16.3	-8.6	-16.01	Upgrade
Shares Outstanding (Basic)	560	560	560	560	560	Upgrade
Shares Outstanding (Diluted)	560	560	560	560	560	Upgrade
EPS (Basic)	-0.02	-0.01	-0.03	-0.02	-0.03	Upgrade
EPS (Diluted)	-0.02	-0.01	-0.03	-0.02	-0.03	Upgrade
Free Cash Flow	0.46	-2.74	-0.94	-10.35	3.44	Upgrade
Free Cash Flow Per Share	0.00	-0.01	-0.00	-0.02	0.01	Upgrade
Gross Margin	46.88%	52.68%	54.00%	53.95%	45.75%	Upgrade
Operating Margin	-9.92%	-1.56%	-17.65%	-9.59%	-27.82%	Upgrade
Profit Margin	-11.84%	-6.44%	-16.96%	-6.36%	-18.08%	Upgrade
Free Cash Flow Margin	0.54%	-2.14%	-0.98%	-7.65%	3.89%	Upgrade
EBITDA	-8.31	-1.73	-16.62	-12.54	-23.94	Upgrade
EBITDA Margin	-9.83%	-1.35%	-17.30%	-9.28%	-27.04%	Upgrade
D&A For EBITDA	0.08	0.27	0.34	0.43	0.69	Upgrade
EBIT	-8.39	-1.99	-16.96	-12.97	-24.63	Upgrade
EBIT Margin	-9.92%	-1.56%	-17.65%	-9.59%	-27.82%	Upgrade

Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.